Keybanc Maintains Overweight on CryoPort, Raises Price Target to $17
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the price target from $15 to $17.
Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the price target from $15 to $17.